Media Summary: As the number of poorly soluble molecules entering the pipeline has increased, the application of Drug molecules with poor water solubility or limited bioavailability present significant clinical challenges. One solution is to ... IQ Consortium Analytical Leadership Group Characterization of

Webinar Amorphous Solid Dispersions Overcoming - Detailed Analysis & Overview

As the number of poorly soluble molecules entering the pipeline has increased, the application of Drug molecules with poor water solubility or limited bioavailability present significant clinical challenges. One solution is to ... IQ Consortium Analytical Leadership Group Characterization of Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ... The talk was given within the NordicPOP WP2/CRS Nordic Local Chapter By replacing solvent-based spray drying with a rapid, solvent-free fusion process, KinetiSol delivers

Dr. Frank Romanski speaks about the the role of excipient selection and key characteristics in In the Thought-Leadership Series on Solubilization with Pharmaceutical Technology Rita Peters and Nigel Langley discuss how ...

Photo Gallery

Webinar: Amorphous Solid Dispersions: Overcoming Scale Up Challenges with Next Generation Technology
Modelling amorphous solid dispersion release mechanisms
Contemporary Opportunities & Challenges: Characterizing Crystallinity in Amorphous Solid Dispersions
Recent Advances in Amorphous Solid Dispersions: Formulation and Characterization Strategies
EUDRATEC® SoluFlow: Free-flowing amorphous solid dispersions for enhanced drug solubility | Evonik
Amorphous Solid Dispersion — An Ideal Formulation Approach to Improve Developability
Webinar Highlights: Modelling amorphous solid dispersion (ASD) release mechanisms
Amorphous Drug Research and Development by Thomas Rades
Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden
Overcoming Late Stage Formulations & Manufacturing Challenges with KinetiSol Technology
Role of Excipients in Amorphous Solid Dispersions
Overcoming Solubility Challenges
View Detailed Profile
Webinar: Amorphous Solid Dispersions: Overcoming Scale Up Challenges with Next Generation Technology

Webinar: Amorphous Solid Dispersions: Overcoming Scale Up Challenges with Next Generation Technology

As the number of poorly soluble molecules entering the pipeline has increased, the application of

Modelling amorphous solid dispersion release mechanisms

Modelling amorphous solid dispersion release mechanisms

Drug molecules with poor water solubility or limited bioavailability present significant clinical challenges. One solution is to ...

Contemporary Opportunities & Challenges: Characterizing Crystallinity in Amorphous Solid Dispersions

Contemporary Opportunities & Challenges: Characterizing Crystallinity in Amorphous Solid Dispersions

IQ Consortium Analytical Leadership Group Characterization of

Recent Advances in Amorphous Solid Dispersions: Formulation and Characterization Strategies

Recent Advances in Amorphous Solid Dispersions: Formulation and Characterization Strategies

Recent Advances in

EUDRATEC® SoluFlow: Free-flowing amorphous solid dispersions for enhanced drug solubility | Evonik

EUDRATEC® SoluFlow: Free-flowing amorphous solid dispersions for enhanced drug solubility | Evonik

Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ...

Amorphous Solid Dispersion — An Ideal Formulation Approach to Improve Developability

Amorphous Solid Dispersion — An Ideal Formulation Approach to Improve Developability

In this

Webinar Highlights: Modelling amorphous solid dispersion (ASD) release mechanisms

Webinar Highlights: Modelling amorphous solid dispersion (ASD) release mechanisms

Watch the full

Amorphous Drug Research and Development by Thomas Rades

Amorphous Drug Research and Development by Thomas Rades

The talk was given within the NordicPOP WP2/CRS Nordic Local Chapter

Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden

Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden

Register for this

Overcoming Late Stage Formulations & Manufacturing Challenges with KinetiSol Technology

Overcoming Late Stage Formulations & Manufacturing Challenges with KinetiSol Technology

By replacing solvent-based spray drying with a rapid, solvent-free fusion process, KinetiSol delivers

Role of Excipients in Amorphous Solid Dispersions

Role of Excipients in Amorphous Solid Dispersions

Dr. Frank Romanski speaks about the the role of excipient selection and key characteristics in

Overcoming Solubility Challenges

Overcoming Solubility Challenges

In the Thought-Leadership Series on Solubilization with Pharmaceutical Technology Rita Peters and Nigel Langley discuss how ...

Hot Melt Extrusion: Accelerating Drug Development for Poorly Soluble APIs

Hot Melt Extrusion: Accelerating Drug Development for Poorly Soluble APIs

Register for this